Journal of Cataract & Refractive Surgery
Volume 32, Issue 9 , Pages 1474-1482, September 2006

Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: Pharmacokinetic-response curve

From a private clinical practice, Rockville Centre, New York, USA

Accepted 3 April 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Presented in part at the ASCRS Symposium on Cataract, IOL and Refractive Surgery, Washington, DC, USA, April 2005.Supported in part by an unrestricted grant from Allergan Inc., Irvine, California, and the Lions Eye Bank for Long Island, Long Island, New York, USA.Drs. Donnenfeld, Perry, and Wittpenn are consultants to Allergan Pharmaceuticals. No other author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(06)00657-2

doi:10.1016/j.jcrs.2006.04.009

Journal of Cataract & Refractive Surgery
Volume 32, Issue 9 , Pages 1474-1482, September 2006

Article Tools

* Image Usage & Resolution